Dr. Steven Schild, MD

• Radiation Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Mayo Clin College Of Medicine

  Residency Hospital, 1989

• Mayo Clin College Of Medicine

  Internship Hospital, 1986

• Brain Metastases From Melanoma Is There a Role for Concurrent Temozolomide in Addition to Whole Brain Radiation Therapy?, 2017-10-25

• Virtual Particle Monte Carlo (VPMC), a new concept to avoid simulating secondary particles in proton therapy dose calculation, 2022-08-22

• Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial, 2018-11-02

• A Randomized Phase II Study of Gemcitabine and Carboplatin With or Without Cediranib as First-Line Therapy in Advanced Non-Small Cell Lung Cancer: North Central Cancer Treatment Group Study N0528, 2014-10-06

• Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study, 2018-10-17

• Robust Intensity-Modulated Proton Therapy to Reduce High Linear Energy Transfer in Organs at Risk, 2017-10-26

• Exploratory study of the association of volumetric modulated arc therapy (VMAT) plan robustness with local failure in head and neck cancer, 2017-05-14

• Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC), 2021-07-22

• A Pooled Analysis of Limited Stage Small Cell Lung Cancer Patients Treated with Induction Chemotherapy Followed by Concurrent Platinum-based Chemotherapy and 70 Gy Daily Radiotherapy: CALGB 30904, 2013-10-17

• Brief Report: A Phase II "Window-of-Opportunity” Frontline Study of the mTOR Inhibitor, Temsirolimus Given as a Single Agent in Patients with Advanced NSCLC, an NCCTG Study, 2017-12-14

• A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases, 2017-04-24

• Deep-Learning-based Fast and Accurate 3D CT Deformable Image Registration in Lung Cancer, 2023-04-21

• Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC), 2015-03-26

• Correlation Between Polymorphisms of the Reduced Folate Carrier Gene (SLC19A1) and Survival After Pemetrexed-Based Therapy in Non-small Cell Lung Cancer A North Central Cancer Treatment Group-Based Exploratory Study, 2017-12-07

• Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Findings Based on North Central Cancer Treatment Group (NCCTG) Trials, 2010-10-19

• Mixed Integer Programming with Dose-Volume Constraints in Intensity-Modulated Proton Therapy, 2017-07-06

• The First Survival Score for Patients Aged =80 Years Irradiated for Brain Metastases, 2022-09-30

• Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost, 2022-08-10

• A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses, 2015-04-15

• A randomized double-blind phase II study of the Seneca Valley Virus (NTX-010) vs placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at least 4 cycles of platinum-based chemotherapy: NCCTG (Alliance) N0923 Study, 2019-10-09

• A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone, 2014-09-20

• A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression, 2016-04-25

• Positive Interaction Between Prophylactic Cranial Irradiation And Maintenance Sunitinib For Untreated Extensive Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis Of CALGB 30504 (Alliance), 2015-12-24

• Robust Optimization in IMPT Using Quadratic Objective Functions to account for the minimum MU constraint, 2017-12-05

• Development of a treatment planning protocol for prostate treatments using intensity modulated radiotherapy, 2001-03-01

• Intensity-Modulated Proton Therapy (IMPT) Interplay Effect Evaluation of Asymmetric Breathing with Simultaneous Uncertainty Considerations in Patients with Non-Small Cell Lung Cancer, 2020-10-13

• Radiotherapy with or without Decompressive Surgery for Metastatic Spinal Cord Compression: A Retrospective Matched-Pair Study Including Data from Prospectively Evaluated Patients, 2022-02-28

• Beam mask and sliding window-facilitated deep learning-based accurate and efficient dose prediction for pencil beam scanning proton therapy, 2023-05-29

• Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons, 2019-06-17

• Early Identification of Pneumonitis in Patients Irradiated for Lung Cancer-Final Results of the PARALUC Trial, 2023-01-04

• Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer, 2021-09-08

• An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer, 2016-03-17

• Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?, 2014-12-04

• Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma, 2016-07-01

• Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases, 2019-02-16

• Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose, 2021-09-29

• Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data, 2013-06-01

• Beam angle comparison for distal esophageal carcinoma patients treated with intensity-modulated proton therapy, 2020-10-15

• Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy, 2017-01-03

• A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression, 2022-08-07

• Phase I Study of Accelerated Hypofractionated Radiotherapy with Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer: CALGB 31102 (Alliance), 2018-01-31

• An Easy-To-Use Survival Score Compared to Existing Tools for Older Patients with Cerebral Metastases from Colorectal Cancer, 2020-03-30

• NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer, 2015-07-17

• Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials, 2021-01-07

• Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 1: Consistent Organs at Risk Management with Advanced Image Guidance, 2022-12-20

• A New Survival Score for Patients =65 Years Assigned to Radiotherapy of Bone Metastases, 2022-09-26

• A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer, 2015-08-19

• Exploratory study of the association of volumetric modulated arc therapy ( VMAT ) plan robustness with local failure in head and neck cancer, 2017-05-14

• The clinical case for proton beam therapy, 2012-10-22

• A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression, 2014-08-14

• Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer, 2014-12-11

• Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience, 2022-07-05

• Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance, 2022-12-21

• Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617, 2021-12-08

• Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression-An Additional Analysis of Patients from Two Prospective Trials, 2022-05-22

• A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321, 2014-09-21

• Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2for definitive radiochemotherapy of locally advanced head-and-neck cancers, 2016-07-08